Latest Industry Insights

In this interview, we speak to Dr. Simon Chandler, CEO of Rinri Therapeutics, to learn more about a new surgical method of accessing the human cochlea which could pave the way for new therapies for hearing loss.

In this interview, we speak to Vikram Devgan at NanoString Technologies to learn more about how added context from spatial biology techniques can provide more detailed insights during tissue analysis.

There remains an active debate within the psychedelic community about the importance of psychedelic experiences to these drugs’ therapeutic effects. Delix Therapeutics is developing compounds, called psychoplastogens, that act similarly to psychedelic compounds at the molecular level but do not induce hallucinations. We spoke with the Delix team to find out more about their research's progress.

Technology Networks spoke with Arvind Kothandaraman to find out about the technologies underpinning syndromic testing, recent advances in the field and its possible role in pandemic prevention.

This article discusses the importance of data lineage and traceability for academic labs looking to maximize their publishing potential.

This article discusses how specialized charge detection mass spectrometers have been developed to enable simultaneous charge detection and decipher large and complex macromolecules, ultimately increasing accuracy and providing high-resolution measurements for better analysis of biotherapeutics.

There is widespread concern about the characteristics of PFAS and its impacts on human health. Can a protein biosensor help in this fight?

To understand how machine learning methods and new software capabilities are helping proteomics researchers gain greater depth in their analyses, Technology Networks recently interviewed Tharan Srikumar, product manager in bioinformatics at Bruker Daltonics.

Technology Networks spoke to Dr. Cenk Sumen, chief scientific officer of MaxCyte, about their pioneering cell engineering platform.

Developing and manufacturing biotherapeutics at scale requires thorough analysis of the active substance’s characteristics to ensure it fulfils both efficacy and safety requirements. Analytical technologies, such as mass spectrometry, are key tools adopted in this process.